… biology that afflicts patients when they present with symptoms decades after the pathologies started in the … novel drug discovery efforts. Hypothesis: We have started with human data and identified a target, with genetic and …

… Today,  Deep Brain Stimulation  (DBS) is the most commonly used surgical procedure to treat people with Parkinson’s disease (PD).  For many, the difference …

… prasinezumab announced this week that the drug is moving into the critical, Phase III stage of clinical trials. If … first disease-modifying medications for Parkinson’s to become available to the public.  Prasinezumab targets a … maintain their quality of life for longer than they would without the drug? In the best-case scenario, the drug would …

… Today the Parkinson Study Group published in JAMA Neurology that with medical supervision, it is possible to safely raise … One quick, very important note: Inosine is available commercially as a dietary supplement, but patients should …

… Photo courtesy of "New York Times Magazine." Michael J. Fox sat down for an intimate interview with  New York Times Magazine  columnist David Marchese. In a series of …

… life-death switch that instructs aged and overworked cells to self-destruct. We hypothesize that hyper-activation of … brain tissue for markers of UPR activation from people with and without PD as well pre-clinical models of the … switch and test them in pre-clinical models. Anticipated Outcome:           Based on preliminary work by ourselves and …